{"name": "Vicept Therapeutics",
 "permalink": "vicept-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/vicept-therapeutics",
 "homepage_url": "http://www.vicepttx.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@vicepttx.com",
 "phone_number": "484.324.2930",
 "description": "",
 "created_at": "Thu Jul 01 02:15:07 UTC 2010",
 "updated_at": "Mon Jul 05 22:03:03 UTC 2010",
 "overview": "\u003Cp\u003EVicept\u00e2\u201e\u00a2 (Vicept Therapeutics, Inc.), based in Malvern, Pennsylvania, is a privately held specialty biopharmaceutical company founded in August, 2009 with a mission to develop the first effective topically applied-therapy directed toward the erythema (skin redness) of rosacea and other dermatologic disorders characterized by redness and or \u0026#8216;flushing\u0026#8217; of the skin.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       90],
      "assets/images/resized/0009/2197/92197v1-max-150x150.png"],
     [[185,
       112],
      "assets/images/resized/0009/2197/92197v1-max-250x250.png"],
     [[185,
       112],
      "assets/images/resized/0009/2197/92197v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Director, President \u0026 CEO",
    "person":
     {"first_name": "Neal",
      "last_name": "Walker",
      "permalink": "neal-walker",
      "image": null}},
   {"is_past": false,
    "title": "CSO",
    "person":
     {"first_name": "Stuart",
      "last_name": "D. Shanler",
      "permalink": "stuart-d-shanler",
      "image": null}},
   {"is_past": false,
    "title": "COO",
    "person":
     {"first_name": "Christopher",
      "last_name": "Powala",
      "permalink": "christopher-powala",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Frank",
      "last_name": "Ruffo",
      "permalink": "frank-ruffo",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$16M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://vicepttx.com/pdf/Vicept%20Release%20Completes%20Series%20A%206.30.10.pdf",
    "source_description": "Vicept Therapeutics Secures $10 Million to Complete Series A Funding",
    "raised_amount": 16000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 6,
    "funded_day": 30,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Vivo Ventures",
         "permalink": "vivo-ventures",
         "image":
          {"available_sizes":
            [[[150,
               62],
              "assets/images/resized/0004/6854/46854v1-max-150x150.png"],
             [[200,
               83],
              "assets/images/resized/0004/6854/46854v1-max-250x250.png"],
             [[200,
               83],
              "assets/images/resized/0004/6854/46854v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Sofinnova Ventures",
         "permalink": "sofinnova-ventures",
         "image":
          {"available_sizes":
            [[[150,
               26],
              "assets/images/resized/0003/0428/30428v1-max-150x150.jpg"],
             [[194,
               34],
              "assets/images/resized/0003/0428/30428v1-max-250x250.jpg"],
             [[194,
               34],
              "assets/images/resized/0003/0428/30428v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Fidelity Biosciences",
         "permalink": "fidelity-biosciences-2",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0005/0044/50044v1-max-150x150.png"],
             [[233,
               79],
              "assets/images/resized/0005/0044/50044v1-max-250x250.png"],
             [[233,
               79],
              "assets/images/resized/0005/0044/50044v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition":
  {"price_amount": 275000000.0,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "http://www.fiercebiotech.com/story/allergan-scoops-fledgling-vicept-275m-buyout-pact/2011-07-19?utm_medium=rss\u0026utm_source=rss",
   "source_description": "Allergan scoops up fledgling Vicept in $275M buyout pact",
   "acquired_year": 2011,
   "acquired_month": 7,
   "acquired_day": 19,
   "acquiring_company":
    {"name": "Allergan",
     "permalink": "allergan",
     "image":
      {"available_sizes":
        [[[150,
           45],
          "assets/images/resized/0007/6186/76186v1-max-150x150.png"],
         [[245,
           75],
          "assets/images/resized/0007/6186/76186v1-max-250x250.png"],
         [[245,
           75],
          "assets/images/resized/0007/6186/76186v1-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "101 Lindenwood Drive",
    "address2": "Suite 430",
    "zip_code": "19355",
    "city": "Malvern",
    "state_code": "PA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}